NVCT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Nuvectis Pharma Inc

NASDAQ | NVCT

6.21

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 16, 2025)

$157.58M

Market Cap

-

P/E Ratio

-1.16

EPS

$11.80

52 Week High

$4.44

52 Week Low

HEALTHCARE

Sector

NVCT Chart

Recent Chart
Price Action

NVCT Technicals

Tags:

NVCT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$20M
Selling General And Administrative $6.9M
Research And Development $13M
Operating Expenses $20M
Investment Income Net -
Net Interest Income $847K
Interest Income $847K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$19M
Income Tax Expense -$19M
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$20M
Ebitda -$19M
Net Income -$19M

Revenue & Profitability

Earnings Performance

NVCT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $19M
Total Current Assets $19M
Cash And Cash Equivalents At Carrying Value $19M
Cash And Short Term Investments $19M
Inventory -
Current Net Receivables -
Total Non Current Assets $0
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $74K
Other Non Current Assets -
Total Liabilities $8.9M
Total Current Liabilities $8.9M
Current Accounts Payable $2.5M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $6.4M
Other Non Current Liabilities -
Total Shareholder Equity $9.7M
Treasury Stock -
Retained Earnings -$73M
Common Stock -
Common Stock Shares Outstanding $17M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$12M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $12M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$20M
Selling General And Administrative $6.9M
Research And Development $13M
Operating Expenses $20M
Investment Income Net -
Net Interest Income $847K
Interest Income $847K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$19M
Income Tax Expense -$19M
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$20M
Ebitda -$19M
Net Income -$19M

NVCT News

NVCT Profile

Nuvectis Pharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.

ADAP
+22.82%
$0.08
CODX
+80.75%
$0.63
CGBS
-39.47%
$0.03
MULN
+9.26%
$0.07
TURB
+359.25%
$12.40
BITF
+15.32%
$2.86
NVDA
-1.61%
$174.88
SNAP
+3.11%
$7.69
NIO
+8.16%
$7.02
APVO
+4.16%
$1.50
MARA
+7.94%
$17.53
KDLY
-55.39%
$1.24
GRAB
+2.85%
$6.31
TSLA
+2.82%
$421.62
AAL
-0.95%
$12.41
OPI
-5.54%
$0.83
DNN
-3.10%
$2.50
WBD
-6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC
-45.91%
$0.12
PLUG
+7.00%
$1.68
AXDX
-61.36%
$0.03
SOFI
-0.90%
$27.42
SOUN
+3.52%
$14.69
SLNH
+3.79%
$0.96
NFE
+44.92%
$2.00
AAPL
+0.61%
$238.15
RIVN
+5.29%
$14.32
F
-0.59%
$11.61
JOBY
+1.77%
$14.37
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
RIOT
+5.03%
$17.52
BMNR
+5.31%
$55.93
ORCL
+1.46%
$306.58
RR
-0.51%
$3.87
CJET
+0.43%
$0.11
BTG
-1.59%
$4.32
PFE
-0.39%
$23.87
BGI
+58.97%
$1.35
INTC
+2.13%
$25.30
BINI
-15.62%
$0.06
ATYR
+6.40%
$1.08
RAYA
-1.47%
$0.04
RGTI
+4.11%
$20.00
ATCH
-12.66%
$0.86
BOXL
+45.66%
$2.52
ABEV
+1.28%
$2.36
QS
-2.17%
$10.13
CNFR
+55.53%
$1.76
HIMS
-5.35%
$51.07
RKLB
-12.64%
$47.20
RMBL
+60.50%
$3.21
BTE
+10.59%
$2.61
BBD
+0.78%
$3.20
DVLT
+32.99%
$0.44
ADD
-25.47%
$0.05
AMZN
+1.13%
$234.05
TLRY
+3.38%
$1.22
VALE
+0.87%
$10.92
ONDS
-4.54%
$6.09
WULF
-2.50%
$10.49
HOOD
+2.22%
$117.38
ITUB
0.00%
$7.14
IREN
-1.85%
$36.45
SRM
+53.27%
$10.30
QBTS
+3.68%
$18.99
KEY
-1.14%
$18.62
GOOGL
-0.17%
$251.16
LPSN
-22.92%
$0.68
CAN
-1.22%
$0.80
BAC
+0.13%
$50.66
NOK
+1.20%
$4.60
IONQ
+5.31%
$62.25
AIIO
+3.42%
$1.51
NWTN
+3.42%
$1.51
PLTR
-0.49%
$170.36
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CLSK
+8.84%
$11.20
ORIS
-23.42%
$0.13
CRWV
-1.42%
$118.75
QUBT
+0.20%
$16.87
WLGS
-5.57%
$0.04
FAAS
-23.86%
$0.09
CIFR
+6.40%
$11.54
RZLV
-0.79%
$7.65
AMD
-0.43%
$160.46
JD
+3.24%
$34.71
RIG
+4.98%
$3.47
ACHR
-0.53%
$9.07
ETWO
0.00%
$3.30
CVE
+2.65%
$17.61
HBAN
-1.13%
$17.43
LYFT
-1.22%
$20.19
BURU
-8.18%
$0.13
BABA
+2.63%
$162.21
CLF
-1.42%
$11.72
AMCR
+1.50%
$8.40
GOOG
-0.13%
$251.42
ADAP
+22.82%
$0.08
CODX
+80.75%
$0.63
CGBS
-39.47%
$0.03
MULN
+9.26%
$0.07
TURB
+359.25%
$12.40
BITF
+15.32%
$2.86
NVDA
-1.61%
$174.88
SNAP
+3.11%
$7.69
NIO
+8.16%
$7.02
APVO
+4.16%
$1.50
MARA
+7.94%
$17.53
KDLY
-55.39%
$1.24
GRAB
+2.85%
$6.31
TSLA
+2.82%
$421.62
AAL
-0.95%
$12.41
OPI
-5.54%
$0.83
DNN
-3.10%
$2.50
WBD
-6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC
-45.91%
$0.12
PLUG
+7.00%
$1.68
AXDX
-61.36%
$0.03
SOFI
-0.90%
$27.42
SOUN
+3.52%
$14.69
SLNH
+3.79%
$0.96
NFE
+44.92%
$2.00
AAPL
+0.61%
$238.15
RIVN
+5.29%
$14.32
F
-0.59%
$11.61
JOBY
+1.77%
$14.37
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
RIOT
+5.03%
$17.52
BMNR
+5.31%
$55.93
ORCL
+1.46%
$306.58
RR
-0.51%
$3.87
CJET
+0.43%
$0.11
BTG
-1.59%
$4.32
PFE
-0.39%
$23.87
BGI
+58.97%
$1.35
INTC
+2.13%
$25.30
BINI
-15.62%
$0.06
ATYR
+6.40%
$1.08
RAYA
-1.47%
$0.04
RGTI
+4.11%
$20.00
ATCH
-12.66%
$0.86
BOXL
+45.66%
$2.52
ABEV
+1.28%
$2.36
QS
-2.17%
$10.13
CNFR
+55.53%
$1.76
HIMS
-5.35%
$51.07
RKLB
-12.64%
$47.20
RMBL
+60.50%
$3.21
BTE
+10.59%
$2.61
BBD
+0.78%
$3.20
DVLT
+32.99%
$0.44
ADD
-25.47%
$0.05
AMZN
+1.13%
$234.05
TLRY
+3.38%
$1.22
VALE
+0.87%
$10.92
ONDS
-4.54%
$6.09
WULF
-2.50%
$10.49
HOOD
+2.22%
$117.38
ITUB
0.00%
$7.14
IREN
-1.85%
$36.45
SRM
+53.27%
$10.30
QBTS
+3.68%
$18.99
KEY
-1.14%
$18.62
GOOGL
-0.17%
$251.16
LPSN
-22.92%
$0.68
CAN
-1.22%
$0.80
BAC
+0.13%
$50.66
NOK
+1.20%
$4.60
IONQ
+5.31%
$62.25
AIIO
+3.42%
$1.51
NWTN
+3.42%
$1.51
PLTR
-0.49%
$170.36
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CLSK
+8.84%
$11.20
ORIS
-23.42%
$0.13
CRWV
-1.42%
$118.75
QUBT
+0.20%
$16.87
WLGS
-5.57%
$0.04
FAAS
-23.86%
$0.09
CIFR
+6.40%
$11.54
RZLV
-0.79%
$7.65
AMD
-0.43%
$160.46
JD
+3.24%
$34.71
RIG
+4.98%
$3.47
ACHR
-0.53%
$9.07
ETWO
0.00%
$3.30
CVE
+2.65%
$17.61
HBAN
-1.13%
$17.43
LYFT
-1.22%
$20.19
BURU
-8.18%
$0.13
BABA
+2.63%
$162.21
CLF
-1.42%
$11.72
AMCR
+1.50%
$8.40
GOOG
-0.13%
$251.42
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.